Skip to main navigation Skip to search Skip to main content

Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

25 Citations (Scopus)
63 Downloads (Pure)
Original languageEnglish
Article numbere129
JournalHemaSphere
Volume8
Issue number8
DOIs
Publication statusPublished - Aug 2024

Bibliographical note

© 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association.

Cite this